scholarly article | Q13442814 |
P356 | DOI | 10.1080/14622200020032060 |
P8608 | Fatcat ID | release_edgctnqryfbdhhgv4zyng4ulsq |
P698 | PubMed publication ID | 11260807 |
P5875 | ResearchGate publication ID | 12071577 |
P2093 | author name string | Wehner JM | |
Collins AC | |||
Gould TJ | |||
P433 | issue | 1 | |
P921 | main subject | nicotine | Q12144 |
P304 | page(s) | 17-24 | |
P577 | publication date | 2001-02-01 | |
P1433 | published in | Nicotine and Tobacco Research | Q15762854 |
P1476 | title | Nicotine enhances latent inhibition and ameliorates ethanol-induced deficits in latent inhibition | |
P478 | volume | 3 |
Q45022273 | A pre-clinical study showing how dopaminergic drugs administered during pre-exposure can impair or facilitate latent inhibition |
Q27345275 | Alcohol and nicotine interactions: pre-clinical models of dependence |
Q34678115 | Chronic nicotine treatment differentially modifies acute nicotine and alcohol actions on GABA(A) and glutamate receptors in hippocampal brain slices |
Q41842706 | Coantagonism of glutamate receptors and nicotinic acetylcholinergic receptors disrupts fear conditioning and latent inhibition of fear conditioning |
Q56638508 | Cognitive Disinhibition, Creativity, and Psychopathology |
Q44393725 | Ethanol disrupts fear conditioning in C57BL/6 mice |
Q44980292 | Latent inhibition of cued fear conditioning: an NMDA receptor-dependent process that can be established in the presence of anisomycin |
Q46798702 | Methylphenidate and nicotine focus responding to an informative discrete CS over successive sessions of appetitive conditioning |
Q37473457 | Neuronal nicotinic acetylcholine receptors as pharmacotherapeutic targets for the treatment of alcohol use disorders |
Q36137598 | Neuronal nicotinic acetylcholine receptors: neuroplastic changes underlying alcohol and nicotine addictions |
Q44558645 | Nicotine enhances contextual fear conditioning in C57BL/6J mice at 1 and 7 days post-training |
Q50660588 | Nicotine enhances contextual fear memory reconsolidation in rats |
Q44607180 | Nicotine produces a within-subject enhancement of contextual fear conditioning in C57BL/6 mice independent of sex |
Q44026242 | Nicotine-alcohol interactions and cognitive function in rats |
Q35025118 | Nicotinic cholinergic modulation: galantamine as a prototype. |
Q36039402 | Positive and negative effects of alcohol and nicotine and their interactions: a mechanistic review. |
Q34926526 | Pro-cognitive and antipsychotic efficacy of the alpha7 nicotinic partial agonist SSR180711 in pharmacological and neurodevelopmental latent inhibition models of schizophrenia. |
Q48234732 | Reversible inactivation of the entorhinal cortex disrupts the establishment and expression of latent inhibition of cued fear conditioning in C57BL/6 mice |
Q33999521 | Scopolamine induces disruption of latent inhibition which is prevented by antipsychotic drugs and an acetylcholinesterase inhibitor. |
Q36364247 | Smoking as a complex but critical covariate in neurobiological studies of posttraumatic stress disorders: a review |
Q35071686 | The "two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment |
Q46575771 | The effects of DHBE and MLA on nicotine-induced enhancement of contextual fear conditioning in C57BL/6 mice |
Q30489302 | The genetic components of alcohol and nicotine co-addiction: from genes to behavior |
Q46440592 | Towards an animal model of an antipsychotic drug-resistant cognitive impairment in schizophrenia: scopolamine induces abnormally persistent latent inhibition, which can be reversed by cognitive enhancers but not by antipsychotic drugs |
Q38129470 | Varenicline and neuronal nicotinic acetylcholine receptors: a new approach to the treatment of co-occurring alcohol and nicotine addiction? |
Q35046256 | Varenicline, a partial agonist at neuronal nicotinic acetylcholine receptors, reduces nicotine-induced increases in 20% ethanol operant self-administration in Sprague-Dawley rats |
Q35785041 | Withdrawal From Chronic Nicotine Reduces Thyroid Hormone Levels and Levothyroxine Treatment Ameliorates Nicotine Withdrawal-Induced Deficits in Hippocampus-Dependent Learning in C57BL/6J Mice |
Search more.